Concepedia

Ludmila Prudkin

LP

Statistics

Publications

31

Citations

6.1K

H-Index

29

Active since

2007

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Memorial Sloan Kettering Cancer Center

Universitat Autònoma de Barcelona

Vall d'Hebron Institut de Recerca

Vall d'Hebron Institute of Oncology

Ludmila Prudkin is an author at The University of Texas MD Anderson Cancer Center specializing in oncology, medicine, and molecular oncology.

ORCID

Publications per year

2007–2017

31

Publications

31

Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group

M. Dowsett, Torsten O. Nielsen, Roger A’Hern et al. · JNCI Journal of the National Cancer Institute · 2011 · 2K citations · Full text

, , +8

TGF-β Receptor Inhibitors Target the CD44high/Id1high Glioma-Initiating Cell Population in Human Glioblastoma

Judit Anido, Andrea Sáez‐Borderías, Alba Gonzàlez-Juncà et al. · Cancer Cell · 2010 · 576 citations · Full text

, , +14

PI3K inhibition results in enhanced HER signaling and acquired ERK dependency in HER2-overexpressing breast cancer

Violeta Serra, Maurizio Scaltriti, Ludmila Prudkin et al. · Oncogene · 2011 · 534 citations · Full text

, , +17

Cyclin E amplification/overexpression is a mechanism of trastuzumab resistance in HER2 <sup>+</sup> breast cancer patients

Maurizio Scaltriti, Pieter J.A. Eichhorn, Javier Cortés et al. · Proceedings of the National Academy of Sciences · 2011 · 332 citations

, , +17

<i>PIK3CA</i> Mutations Are Associated With Decreased Benefit to Neoadjuvant Human Epidermal Growth Factor Receptor 2–Targeted Therapies in Breast Cancer

Ian J. Majewski, Paolo Nucíforo, Lorenza Mittempergher et al. · Journal of Clinical Oncology · 2015 · 227 citations · Full text

, , +17

1–5 of 31